Together, these data demonstrate that selective Tn‐R suppression in the perforant pathway confers dual therapeutic benefits: (1) normalization of Aβ neuropathology through modulation of soluble Aβ species, and (2) functional rescue of AD‐associated cognitive deficits spanning recognition memory, spatial navigation, and associative learning domains. This evidence concerns the gene TNR and Cognitive impairment.